16-88647138-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000101.4(CYBA):c.166C>G(p.Arg56Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,611,018 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R56Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000101.4 missense
Scores
Clinical Significance
Conservation
Publications
- granulomatous disease, chronic, autosomal recessive, cytochrome b-negativeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- chronic granulomatous diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000101.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYBA | NM_000101.4 | MANE Select | c.166C>G | p.Arg56Gly | missense | Exon 3 of 6 | NP_000092.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYBA | ENST00000261623.8 | TSL:1 MANE Select | c.166C>G | p.Arg56Gly | missense | Exon 3 of 6 | ENSP00000261623.3 | ||
| CYBA | ENST00000569359.5 | TSL:1 | c.166C>G | p.Arg56Gly | missense | Exon 3 of 5 | ENSP00000456079.1 | ||
| CYBA | ENST00000696161.1 | c.166C>G | p.Arg56Gly | missense | Exon 3 of 6 | ENSP00000512451.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152130Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000814 AC: 2AN: 245838 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1458888Hom.: 0 Cov.: 33 AF XY: 0.00000551 AC XY: 4AN XY: 725772 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.166C>G (p.R56G) alteration is located in exon 3 (coding exon 3) of the CYBA gene. This alteration results from a C to G substitution at nucleotide position 166, causing the arginine (R) at amino acid position 56 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Chronic granulomatous disease Uncertain:1
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 56 of the CYBA protein (p.Arg56Gly). This variant is present in population databases (rs767148046, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with CYBA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1063259). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at